Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Autologous Haemopoietic Stem Cell Transplant”

412 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 412 results

Testing effectiveness (Phase 2)WithdrawnNCT00728585
What this trial is testing

Palifermin in Preventing Oral Mucositis Caused by Chemotherapy and/or Radiation Therapy in Young Patients Undergoing Stem Cell Transplant

Who this might be right for
Gastrointestinal MucositisMalignant Neoplasm
Children's Oncology Group
Testing effectiveness (Phase 2)Study completedNCT01575860
What this trial is testing

Maintenance Lenalidomide in Lymphoma

Who this might be right for
Lymphoma
Abramson Cancer Center at Penn Medicine 8
Testing effectiveness (Phase 2)Study completedNCT03436862
What this trial is testing

Nivolumab Maintenance Therapy After Autologous Stem Cell Transplant in Hodgkin Lymphoma Pts at Relapse/Progression Risk

Who this might be right for
Hodgkin Lymphoma
SCRI Development Innovations, LLC 37
Testing effectiveness (Phase 2)Study completedNCT01412879
What this trial is testing

S1106 Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Patients With Previously Untreated Mantle Cell Lymphoma

Who this might be right for
Lymphoma
SWOG Cancer Research Network 53
Large-scale testing (Phase 3)Study completedNCT00646854
What this trial is testing

Alemtuzumab and CHOP in T-cell Lymphoma

Who this might be right for
Lymphoma, T-Cell, Peripheral
Aarhus University Hospital 136
Testing effectiveness (Phase 2)Looking for participantsNCT06687772
What this trial is testing

CNS-Relapse Prevention in High-Risk Diffuse Large B-cell Lymphoma With Thiotepa-based Autologous Stem Cell Transplant

Who this might be right for
Diffuse Large B Cell Lymphoma
Washington University School of Medicine 36
Large-scale testing (Phase 3)Study completedNCT00566228
What this trial is testing

Two Different Methods of Collecting Stem Cells For an Autologous Stem Cell Transplant in Treating Patients With Diffuse Large Cell Lymphoma

Who this might be right for
Lymphoma
Mayo Clinic 122
Testing effectiveness (Phase 2)WithdrawnNCT03975101
What this trial is testing

Very Small Embryonic-like Stem Cells for Knee Osteoarthritis

Who this might be right for
Stem Cell Transplant ComplicationsKnee Osteoarthritis
Fuda Cancer Hospital, Guangzhou
Testing effectiveness (Phase 2)Looking for participantsNCT04491370
What this trial is testing

Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma

Who this might be right for
B-cell LymphomaBurkitt LymphomaDiffuse Large B Cell Lymphoma+6 more
New York Medical College 20
Large-scale testing (Phase 3)Study completedNCT00049673
What this trial is testing

Thalidomide and Prednisone After Autologous Stem Cell Transplantation Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
NCIC Clinical Trials Group 332
Not applicableWithdrawnNCT02469974
What this trial is testing

Ruxolitinib in Combination With Autotransplant

Who this might be right for
MyelofibrosisMF
Marina Kremyanskaya
Testing effectiveness (Phase 2)Looking for participantsNCT03538899
What this trial is testing

Autologous Gene Therapy for Artemis-Deficient SCID

Who this might be right for
Severe Combined Immunodeficiency
University of California, San Francisco 24
Not applicableWithdrawnNCT01769911
What this trial is testing

Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAIDS-related Diffuse Large Cell LymphomaAIDS-related Diffuse Mixed Cell Lymphoma+42 more
Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)UnknownNCT00417053
What this trial is testing

Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma Who Are Undergoing Surgery With or Without Autologous Bone Marrow or Peripheral Stem Cell Transplant

Who this might be right for
Neuroblastoma
Children's Cancer and Leukaemia Group
Testing effectiveness (Phase 2)Ended earlyNCT04331119
What this trial is testing

Duvelisib Maintenance After Autologous Stem Cell Transplant in T-Cell Lymphomas

Who this might be right for
T-Cell Lymphoma
Washington University School of Medicine 17
Large-scale testing (Phase 3)UnknownNCT04896164
What this trial is testing

Randomized Trial of Curcumin to Reduce Mucositis in Autologous Transplant Setting

Who this might be right for
Oral Mucositis (Ulcerative)
Tata Memorial Centre 190
Testing effectiveness (Phase 2)Ended earlyNCT01078441
What this trial is testing

Bortezomib, Liposomal Doxorubicin Hydrochloride, Dexamethasone, and Cyclophosphamide in Treating Patients With Multiple Myeloma That Relapsed After Autologous Stem Cell Transplant

Who this might be right for
Refractory Multiple Myeloma
National Cancer Institute (NCI) 2
Large-scale testing (Phase 3)UnknownNCT00410631
What this trial is testing

Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma

Who this might be right for
Neuroblastoma
German Society for Pediatric Oncology and Hematology GPOH gGmbH 642
Testing effectiveness (Phase 2)Study completedNCT03159845
What this trial is testing

Zinc as Enhancer in Immune Recovery After Stem Cell Transplantation for Hematological Malignancies

Who this might be right for
Stem Cell Transplant Complications
Azienda Ospedaliero, Universitaria Pisana 20
Testing effectiveness (Phase 2)Looking for participantsNCT06974786
What this trial is testing

Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma

Who this might be right for
Multiple Myeloma, Newly DiagnosedMultiple Myeloma (MM)
SCRI Development Innovations, LLC 100
Load More Results